NKGen Biotech, Inc. financial data

Location
Santa Ana, CA
Fiscal year end
31 December
Latest financial report
10-Q - Q1 2025 - 20 Jan 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 3.7% % -68%
Debt-to-equity -126% % 4.9%
Return On Equity 40% % -79%
Return On Assets -150% % 43%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 130,602,230 shares
Common Stock, Shares, Outstanding 51,306,712 shares 129%
Entity Public Float $13,735,563 USD
Common Stock, Value, Issued $5,000 USD 150%
Weighted Average Number of Shares Outstanding, Basic 45,962,049 shares 110%
Weighted Average Number of Shares Outstanding, Diluted 102,654,719 shares 368%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $9,277,000 USD -39%
General and Administrative Expense $14,734,000 USD -3.5%
Costs and Expenses $24,011,000 USD -21%
Operating Income (Loss) $24,011,000 USD 21%
Nonoperating Income (Expense) $20,016,000 USD 794%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $80,007,000 USD -116%
Income Tax Expense (Benefit) $53,000 USD
Net Income (Loss) Attributable to Parent $23,554,000 USD 71%
Earnings Per Share, Basic -0.96 USD/shares 81%
Earnings Per Share, Diluted -1.33 USD/shares 73%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $6,000 USD -82%
Other Assets, Current $0 USD
Assets, Current $2,381,000 USD 48%
Property, Plant and Equipment, Net $13,024,000 USD -7.9%
Operating Lease, Right-of-Use Asset $341,000 USD -29%
Assets $15,842,000 USD -2.9%
Accounts Payable, Current $15,240,000 USD 19%
Employee-related Liabilities, Current $1,038,000 USD 42%
Accrued Liabilities, Current $252,000 USD -85%
Liabilities, Current $43,888,000 USD 17%
Deferred Income Tax Liabilities, Net $8,000 USD -76%
Operating Lease, Liability, Noncurrent $206,000 USD -41%
Liabilities $66,174,000 USD -7.3%
Retained Earnings (Accumulated Deficit) $191,066,000 USD -14%
Stockholders' Equity Attributable to Parent $50,332,000 USD 8.6%
Liabilities and Equity $15,842,000 USD -2.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $2,800,000 USD 31%
Net Cash Provided by (Used in) Financing Activities $2,646,000 USD -34%
Net Cash Provided by (Used in) Investing Activities $52,000 USD -249%
Common Stock, Shares Authorized 500,000,000 shares 0%
Common Stock, Shares, Issued 51,306,712 shares 129%
Common Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $206,000 USD -2675%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $29,000 USD -90%
Interest Paid, Excluding Capitalized Interest, Operating Activities $131,000 USD 9.2%
Deferred Tax Assets, Valuation Allowance $39,789,000 USD 18%
Deferred Tax Assets, Gross $40,088,000 USD 18%
Operating Lease, Liability $360,000 USD -28%
Depreciation $1,200,000 USD 9.1%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $48,478,000 USD
Lessee, Operating Lease, Liability, to be Paid $430,000 USD -36%
Property, Plant and Equipment, Gross $18,199,000 USD 0%
Operating Lease, Liability, Current $154,000 USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year Two $249,000 USD 2.9%
Lessee, Operating Lease, Liability, to be Paid, Year One $249,000 USD 2.9%
Operating Lease, Weighted Average Discount Rate, Percent 0.224 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $70,000 USD
Deferred Tax Assets, Operating Loss Carryforwards $29,105,000 USD 27%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Unrecognized Tax Benefits $2,797,000 USD 408%
Additional Paid in Capital $140,911,000 USD 15%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization $341,000 USD 16%
Deferred Tax Assets, Net of Valuation Allowance $299,000 USD -20%
Share-based Payment Arrangement, Expense $3,732,000 USD -6.6%
Interest Expense $1,069,000 USD 3044%
Preferred Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%